Oramorph


Combined with:

Paracetamol

Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 41.2%
Cancer Pain 12.7%
Pain 8.8%
Transitional Cell Carcinoma 8.8%
Abdominal Pain 5.9%
Analgesic Therapy 2.9%
Drug Diversion 2.9%
Suicide Attempt 2.9%
Agitation 2.0%
Oropharyngeal Squamous Cell Carcinoma 2.0%
Rheumatoid Arthritis 2.0%
Spinal Pain 2.0%
Breakthrough Pain 1.0%
Gout 1.0%
Hypothyroidism 1.0%
Prophylaxis 1.0%
Pulmonary Arterial Hypertension 1.0%
Squamous Cell Carcinoma 1.0%
Vomiting 45.7%
Narcotic Bowel Syndrome 11.4%
Drug Diversion 5.7%
Pyrexia 5.7%
Somnolence 5.7%
Cerebellar Infarction 2.9%
Overdose 2.9%
Pancreatitis Acute 2.9%
Pneumonia 2.9%
Pneumonitis 2.9%
Renal Failure Acute 2.9%
Skin Ulcer 2.9%
Therapy Cessation 2.9%
Vomiting Projectile 2.9%
Concomitant
Product Used For Unknown Indication 47.1%
Pain 9.5%
Crohn's Disease 4.7%
Drug Use For Unknown Indication 4.6%
Nausea 3.5%
Infection 3.2%
Acute Myeloid Leukaemia 2.4%
Anxiety 2.4%
Prophylaxis 2.4%
B-cell Lymphoma 2.3%
Constipation 2.3%
Rheumatoid Arthritis 2.3%
Sarcoma 2.3%
Depression 2.0%
Neoplasm Malignant 1.9%
Myelodysplastic Syndrome 1.6%
Abdominal Pain 1.5%
Plasma Cell Myeloma 1.5%
Bone Disorder 1.3%
Analgesic Therapy 1.2%
Vomiting 14.3%
White Blood Cell Count Increased 10.7%
Pulmonary Embolism 6.5%
Platelet Count Increased 6.0%
Hyponatraemia 5.4%
Tremor 5.4%
Wheezing 5.4%
Sepsis 4.8%
Suicidal Ideation 4.8%
Dyskinesia 4.2%
Pyrexia 4.2%
Teeth Brittle 4.2%
Somnolence 3.6%
Urinary Tract Infection 3.6%
Renal Failure Acute 3.0%
Respiratory Failure 3.0%
Tongue Ulceration 3.0%
Troponin T Increased 3.0%
Wrong Technique In Drug Usage Process 3.0%
Overdose 2.4%

Drug Data